Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Rivastigmine tartrate (Alias: SDZ-ENA 713, ENA 713)

Catalog No. T1628 Copy Product Info
Purity: 99.66%
😃Good
Rivastigmine tartrate (SDZ-ENA 713) is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.

Rivastigmine tartrate

Copy Product Info
😃Good
Catalog No. T1628
Alias SDZ-ENA 713, ENA 713

Rivastigmine tartrate (SDZ-ENA 713) is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.

Rivastigmine tartrate
Cas No. 129101-54-8
Pack SizePriceUSA StockGlobal StockQuantity
25 mg$47In StockIn Stock
50 mg$55In StockIn Stock
100 mg$81In StockIn Stock
200 mg$108In StockIn Stock
1 mL x 10 mM (in DMSO)$58In StockIn Stock
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.66%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Rivastigmine tartrate (SDZ-ENA 713) is a carbamate-derived reversible CHOLINESTERASE INHIBITOR that is selective for the CENTRAL NERVOUS SYSTEM and is used for the treatment of DEMENTIA in ALZHEIMER DISEASE and PARKINSON DISEASE.
Targets&IC50
AChR:5.5 μM
SynonymsSDZ-ENA 713, ENA 713
Chemical Properties
Molecular Weight400.43
FormulaC14H22N2O2·C4H6O6
Cas No.129101-54-8
SmilesO[C@H]([C@@H](O)C(O)=O)C(O)=O.CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C
Relative Density.no data available
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
Ethanol: 74 mg/mL (184.8 mM), Sonication is recommended.
DMSO: 39 mg/mL (97.4 mM), Sonication is recommended.
H2O: 73 mg/mL (182.3 mM), Sonication is recommended.
Solution Preparation Table
DMSO/H2O/Ethanol
1mg5mg10mg50mg
1 mM2.4973 mL12.4866 mL24.9732 mL124.8658 mL
5 mM0.4995 mL2.4973 mL4.9946 mL24.9732 mL
10 mM0.2497 mL1.2487 mL2.4973 mL12.4866 mL
20 mM0.1249 mL0.6243 mL1.2487 mL6.2433 mL
50 mM0.0499 mL0.2497 mL0.4995 mL2.4973 mL
H2O/Ethanol
1mg5mg10mg50mg
100 mM0.0250 mL0.1249 mL0.2497 mL1.2487 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Rivastigmine tartrate | purchase Rivastigmine tartrate | Rivastigmine tartrate cost | order Rivastigmine tartrate | Rivastigmine tartrate chemical structure | Rivastigmine tartrate formula | Rivastigmine tartrate molecular weight